The Alameda County Public Health Department sends out Health Alerts, Advisories, and Updates regarding communicable disease outbreaks, immunization updates, and other public health concerns to Alameda County clinicians and other partners. See recent releases below.
Sign up for
Subscribe today to AC Alert, Alameda County’s 24/7 notification system, to begin receiving emergency alerts.
Health Care Provider AC Alert Registration Form: Health Updates, Advisories, and Alerts, as well as other pertinent information, are sent out to healthcare providers and other relevant contacts in Alameda County through a Public Health-specific subscription in AC Alert. Healthcare providers can register to receive these communications.
Main AC Alert Registration Form: All Alameda County residents are encouraged to register themselves for AC Alert messages from several Alameda County agencies via other subscription options.
Health Alerts
| ALERT | conveys the highest level of importance; warrants immediate action or attention. |
| ADVISORY | provides important information for a specific incident or situation; may not require immediate action. |
| UPDATE | provides updated information regarding an incident or situation; unlikely to require immediate action. |
August 10, 2022 |
Advisory |
Health Advisory Update: Outpatient COVID-19 Therapeutics The purpose of the attached Health Advisory is to share current COVID-19 therapeutics information with clinicians in Alameda County. Please see our full health advisory for complete information, including the most recent COVID-19 Therapeutics Program Update from CDPH For questions about COVID-19 therapeutics, please contact Arnie Spanjers, MD, Alameda County Public Health Department at arnie.spanjers@acgov.org |
August 01, 2022 |
Advisory |
Clarification Regarding Monkeypox Health Advisory Released on July 27, 2022 On July 27, 2022, the Alameda County Public Health Department (ACPHD) released a health advisory providing updated clinical guidance for monkeypox. Since we released this health advisory, ACPHD has received several questions regarding our updated JYNNEOS vaccine prioritization criteria. To address these questions, we are providing further clarification regarding our vaccine prioritization criteria. Please review full health advisory for additional background and action requested of clinicians. |
July 27, 2022 |
Advisory |
Updated Clinical Provider Guidance for Monkeypox The Alameda County Public Health Department has issued a health advisory to provide clinicians with updated guidance regarding monkeypox. Specifically, this advisory provides updated guidance regarding monkeypox reporting, testing, vaccine prioritization, and treatment. Please review the health advisory for additional background and action requested of clinicians. |
July 21, 2022 |
Advisory |
Make Evusheld Available to Eligible Patients The purpose of this health advisory is to remind clinicians about thebavailability of Evusheld as pre-exposure prophylaxis (PrEP) for COVID-19 in certain adult and pediatric patients (12 years of age and older weighing at least 40 kg). Providers are encouraged to reach out to all patients eligible for Evusheld to discuss risks and benefits and ensure access to this medication. Please visit ACPHD’s Treatment webpage for more information. For questions regarding the distribution of COVID-19 outpatient therapeutic products within ALCO, please contact Cynthia Frankel, RN, Alameda County Therapeutics Distribution Lead at cynthia.frankel@acgov.org For clinical questions about COVID-19 therapeutics,please contact Arnie Spanjers, MD, Alameda County Public Health Department at arnie.spanjers@acgov.org |
May 25, 2022 |
Advisory |
CDC-HAN: COVID-19 Rebound After Paxlovid Treatment The CDC has issued a Health Advisory to provide an update on the potential for recurrence of COVID-19 or “COVID-19 rebound” after Paxlovid treatment. COVID-19 rebound has been reported to occur between 2 and 8 days after initial recovery and is characterized by a recurrence of COVID-19 symptoms OR a new positive viral test after having tested negative. A brief return of symptoms may be part of the natural history of SARS-CoV-2 infection in some persons, independent of treatment with Paxlovid and regardless of vaccination status. Available information suggests that persons treated with Paxlovid who experience COVID-19 rebound have had mild illness; there are no reports of severe disease. Please see the health advisory for recommendations for healthcare providers. For questions regarding the distribution of COVID-19 outpatient therapeutic products within ALCO, please contact Cynthia Frankel, RN, Alameda County Therapeutics Distribution Lead at cynthia.frankel@acgov.org For clinical questions about COVID-19 therapeutics, please contact Arnie Spanjers, MD, Alameda County Public Health Department at arnie.spanjers@acgov.org |
May 24, 2022 |
Advisory |
Cases of Monkeypox Identified in Non-Endemic Countries Including the US The Alameda County Public Health Department has issued a health advisory for clinicians regarding monkeypox in light of reports of global transmission of monkeypox including the United States. As of May 24, 2022, monkeypox virus infections have been confirmed in Australia, Europe and North America including 1 confirmed in a Massachusetts resident – all countries where the virus is non-endemic. In addition, patients with symptoms compatible with monkeypox infection are under investigation in the United States (7) who are all confirmed with Orthopox viral DNA. Cases of monkeypox have been identified since early May 2022; many of the cases have involved men who identify as gay, bisexual or have sex with men (MSM) without a history of travel to an endemic country. Clinical details on these cases, including any hospitalizations or deaths, are currently unknown. Please review the full health advisory for additional background and action requested of clinicians. |
May 19, 2022 |
Advisory |
Homemade Infant Formula to Infants On May 13th, the California Department of Public Health issued a Health Advisory on the current infant formula shortage which includes helpful recommendations for families. The California Department of Public Health/Women, Infants and Children Division (CDPH/WIC) is monitoring reports of widespread low-stock situations, outages, and rationing of powdered infant formula in California. Actions requested of clinicians:
|
April 29, 2022 |
Advisory |
Bebtelovimab + Evusheld appointments available at Total Infusion! We are pleased to announce that Total Infusion remains open to administer both Bebtelovimab (provider and patient referrals) and Evusheld (provider referrals only). The appointment page can be found here: https://totalinfusion.com/book-an-appointment/ or you can call (510) 878-9528 with questions. For general questions about treatment,please contact Arnie Spanjers, MD, Alameda County Public Health Department at arnie.spanjers@acgov.org |
April 26, 2022 |
Advisory |
Recommendations for Adenovirus Testing and Reporting of Children with Acute Hepatitis of Unknown Etiology The CDC and the California Department of Public Health (CDPH) have issued a health advisory regarding a cluster of pediatric cases of hepatitis associated with Adenovirus type 41. Clinicians are requested to report cases of children that meet the following criteria to the local health department within one business day. Reporting criteria: Children <10 years of age with elevated aspartate aminotransferase (AST) or alanine aminotransferase (ALT) (>500 U/L) AND who have an unknown etiology for their hepatitis (with or without any adenovirus testing results, independent of the results) since October 1, 2021 To report cases to Alameda County Public Health Department, contact the Acute Communicable Disease (ACD) Section By phone: at 510-267-3250 option 2, Monday –Friday 8:30am through 5PM. By secure email: acutecd@acgov.org |
April 25, 2022 |
Advisory |
Availability and Use of Treatments for Outpatients with Mild to Moderate COVID-19 The Centers for Disease Control and Prevention (CDC) issued a Health Alert Network (HAN) Health Advisory to provide an update about the availability and use of recommended therapies for COVID-19 and to advise against using unproven treatments that have known or potential harms for outpatients with mild to moderate COVID-19. For patients with mild to moderate COVID-19 who are not hospitalized and who are at increased risk for severe COVID-19 outcomes, several treatment options, including antiviral medications and monoclonal antibodies, are now widely available and accessible. Please see the Health Advisory for full details and note the following:
For general questions about treatment, please contact Arnie Spanjers, MD, Alameda County Public Health Department at arnie.spanjers@acgov.org |
April 01, 2022 |
Advisory |
CAHAN: Use of Outpatient COVID-19 Therapeutics in California On March 30th, the California Department of Public Health (CDPH) issued this alert on the use of outpatient COVID-19 therapeutics in California. As supply of therapeutics has increased and overall COVID-19 cases have decreased across California, there is no longer a limited supply of COVID-19 therapeutic treatments in most locations. As of this writing, all outpatients with mild to moderate COVID-19 who are at risk for disease progression should be offered treatment if eligible based on the product Emergency Use Authorizations (EUAs). Treatment should be offered regardless of vaccination status and because of the predominance of the Omicron sub-variant BA.2, sotrovimab is no longer authorized for use in California. This Health Alert also includes information on the new Test to Treat Locator. Please see the updated Alameda County Health Advisory. You are also encouraged to view yesterday’s webinar, COVID-19 Outpatient Therapeutics + Pre-Exposure Prophylaxis, with Dr. Nicholas Moss, Alameda County Health Officer, and Dr. John Openshaw. Dr. Openshaw is an infectious disease physician and researcher who leads the COVID-19 Clinical Team at the California Department of Public Health. He is on the faculty at Stanford University School of Medicine and regularly sees adult infectious disease patients in San Mateo and Santa Clara Counties. To learn more about COVID-19 drug-drug interactions, please check out the Liverpool COVID-19 Drug Interaction Tool. For questions regarding the distribution of COVID-19 outpatient therapeutic products within ALCO, please contact Cynthia Frankel, RN, Alameda County Therapeutics Distribution Lead at cynthia.frankel@acgov.org. For clinical questions about COVID-19 therapeutics, please contact Arnie Spanjers, MD, Alameda County Public Health Department at arnie.spanjers@acgov.org |
March 31, 2022 |
Advisory |
Outpatient Therapies for the Treatment and Prevention of COVID-19 in High-Risk Patients The purpose of this Health Advisory is to inform clinicians in Alameda County about the availability of outpatient therapies for high-risk patients with 1) mild to moderate COVID-19 illness who are not yet hospitalized; or 2) ongoing risk of exposure to COVID-19. When resources are limited, therapy should be prioritized for patients who are at the highest risk of progressing to severe COVID-19, as described in the NIH Panel’s interim statement. As availability increases, it may be possible to offer available therapies to all eligible patients.
Please also visit our COVID-19 website. For questions regarding the distribution of COVID-19 outpatient therapeutic products within ALCO, please contact Cynthia Frankel, RN, Alameda County Therapeutics Distribution Lead at cynthia.frankel@acgov.org. For clinical questions about COVID-19 therapeutics, please contact Arnie Spanjers, MD, Alameda County Public Health Department at arnie.spanjers@acgov.org |